Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMarks & Spencer Regulatory News (MKS)

Share Price Information for Marks & Spencer (MKS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 296.90
Bid: 297.20
Ask: 297.40
Change: -5.40 (-1.79%)
Spread: 0.20 (0.067%)
Open: 301.70
High: 302.90
Low: 295.20
Prev. Close: 302.30
MKS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

12 Jun 2013 13:20

RNS Number : 8908G
Marks & Spencer Group PLC
12 June 2013
 



NOTIFICATION OF TRANSACTIONS OF DIRECTORS, PERSONS DISCHARGING MANAGERIAL RESPONSIBILITY OR CONNECTED PERSONS

This form is intended for use by an issuer to make a RIS notification required by DTR 3.1.4R(1).

 

(1)

An issuer making a notification in respect of a transaction relating to the shares or debentures of the issuer should complete boxes 1 to 16, 23 and 24.

(2)

An issuer making a notification in respect of a derivative relating to the shares of the issuer should complete boxes 1 to 4, 6, 8, 13, 14, 16, 23 and 24.

(3)

An issuer making a notification in respect of options granted to a director/person discharging managerial responsibilities should complete boxes 1 to 3 and 17 to 24.

(4)

An issuer making a notification in respect of a financial instrument relating to the shares of the issuer (other than a debenture) should complete boxes 1 to 4, 6, 8, 9, 11, 13, 14, 16, 23 and 24.

 

Please complete all relevant boxes in block capital letters.

 

1. Name of the issuer

MARKS AND SPENCER GROUP PLC

2. State whether the notification relates to

(i) a transaction notified in accordance with DTR 3.1.4R(1)(a); or

(ii) DTR 3.1.4(R)(1)(b) a disclosure made in accordance with section 793 of the Companies Act 2006; or

(iii) both (i) and (ii)

DISCLOSURE RELATES TO POINT (i)

3. Name of person discharging managerial responsibilities/director

JOHN DIXONSTEVEN SHARPSTEVE ROWELAURA WADE-GERY

4. State whether notification relates to a person connected with a person discharging managerial responsibilities/director named in 3 and identify the connected person

SARAH DIXON - CONNECTED PERSON TO JOHN DIXON

5. Indicate whether the notification is in respect of a holding of the person referred to in 3 or 4 above or in respect of a non-beneficial interest

DISCLOSURE RELATES TO POINT 3

6. Description of shares (including class), debentures or derivatives or financial instruments relating to shares

ORDINARY 25p SHARES

7. Name of registered shareholders(s) and, if more than one, the number of shares held by each of them

SEE 9 BELOW

8. State the nature of the transaction

JOHN DIXON - EXERCISE OF 223,054 OPTIONS (WHICH VESTED ON 9 JUNE 2013) FROM THE 2010 DEFERRED SHARE BONUS PLAN (DSBP) AWARD, AND SUBSEQUENT SALE TO COVER TAX AND NI LIABILITY

 - EXERCISE OF 9,149 OPTIONS FROM THE 2009 PERFORMANCE SHARE PLAN (PSP) AWARD (WHICH VESTED ON 24 NOVEMBER 2012), AND SUBSEQUENT SALE OF SHARES TO COVER TAX AND NI LIABILITY

 - EXERCISE OF 25,935 EXECUTIVE SHARE OPTIONS (ESO), AWARDED IN JULY 2004 AND SUBSEQUENT SALE OF SHARES TO COVER THE COST OF THE OPTION (£3.47 PER SHARE) THE TAX AND THE NI LIABILITY

 - SARAH DIXON (CONNECTED PARTY) - SALE OF 6,445 ORDINARY SHARES

 

STEVEN SHARP - EXERCISE OF 267,291 OPTIONS (WHICH VESTED ON 9 JUNE 2013) FROM THE 2010 DEFERRED SHARE BONUS PLAN (DSBP) AWARD, AND SUBSEQUENT SALE TO COVER TAX AND NI LIABILITY

STEVE ROWE- EXERCISE OF 76,934 OPTIONS (WHICH VESTED ON 9 JUNE 2013) FROM THE 2010 DEFERRED SHARE BONUS PLAN (DSBP) AWARD, AND SUBSEQUENT SALE TO COVER TAX AND NI LIABILITY

LAURA WADE-GERY- EXERCISE OF 119,751 SHARES FROM THE RESTRICTED SHARE PLAN (RSP) AWARD (WHICH VESTED ON 25 JULY 2012) AND SUBSEQUENT SALE OF SHARES TO COVER TAX AND NI LIABILITY (SEE NO. 23 FOR ADDITIONAL INFORMATION)

9. Number of shares, debentures or financial instruments relating to shares acquired

NAME

AWARD TYPE

NO. OF OPTIONS EXERCISED

NUMBER OF SHARES SOLD

PRICE

TOTAL SHAREHOLDING FOLLOWING TRANSACTION

JOHN DIXON

DSBP

223,054

105,204

442.15p

276,399

PSP

9,149

4,315

442.15p

ESO

25,935

22,182

442.15p

CONNECTED PARTY

-

6,445

443.74p

STEVEN SHARP

DSBP

267,291

126,070

443.36p

540,781

STEVE ROWE

DSBP

76,934

36,288

442.15p

226,572

LAURA WADE-GERY

RSP

119,751

56,482

445.24p

118,324

 

10. Percentage of issued class acquired (treasury shares of that class should not be taken into account when calculating percentage)

DE MINIMIS

11. Number of shares, debentures or financial instruments relating to shares disposed

SEE 9 ABOVE

12. Percentage of issued class disposed (treasury shares of that class should not be taken into account when calculating percentage) 

DE MINIMIS

13. Price per share or value of transaction

SEE 9 ABOVE

14. Date and place of transaction

LONDON, TUESDAY 11 JUNE 2013

15. Total holding following notification and total percentage holding following notification (any treasury shares should not be taken into account when calculating percentage)

SEE 9 ABOVE

16. Date issuer informed of transaction

WEDNESDAY 12 JUNE 2013

If a person discharging managerial responsibilities has been granted options by the issuer complete the following boxes

 

17 Date of grant

 

………………………………

 

18. Period during which or date on which it can be exercised

 

………………………………

 

19. Total amount paid (if any) for grant of the option

 

………………………………

 

20. Description of shares or debentures involved (class and number)

 

………………………………

………………………………

 

21. Exercise price (if fixed at time of grant) or indication that price is to be fixed at the time of exercise

 

………………………………

 

22. Total number of shares or debentures over which options held following notification

 

………………………………

 

23. Any additional information

LAURA WADE-GERY - RSP EXERCISE - THIS AWARD WAS MADE IN CONNECTION WITH LAURA'S APPOINTMENT AS EXECUTIVE DIRECTOR, MULTI-CHANNEL E-COMMERCE, TO COMPENSATE HER FOR INCENTIVE AWARDS THAT WERE FORFEITED ON CESSATION OF HER ROLE WITH HER PREVIOUS EMPLOYER.

24. Name of contact and telephone number for queries

ANTHONY CLARKE

020 8718 9940

Name and signature of duly authorised officer of issuer responsible for making notification

ANTHONY CLARKE

Date of notification

12 JUNE 2013

END

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSLLLFFXQFFBBV
Date   Source Headline
3rd Jun 202410:00 amRNSAnnual Financial Report
3rd Jun 20249:00 amRNSTotal Voting Rights
30th May 202412:41 pmRNSDirector/PDMR Shareholding
29th May 20244:01 pmRNSCFO announcement
29th May 20242:07 pmRNSDirector/PDMR Shareholding
28th May 20242:04 pmRNSAndrew Fisher to stand down from the Board
22nd May 20247:00 amRNSFinal Results
1st May 20249:00 amRNSTotal Voting Rights
30th Apr 20241:13 pmRNSDirector/PDMR Shareholding
2nd Apr 20249:00 amRNSTotal Voting Rights
28th Mar 20245:23 pmRNSHolding(s) in Company
28th Mar 20243:07 pmRNSDirector/PDMR Shareholding
26th Mar 20243:07 pmRNSDirector/PDMR Shareholding
7th Mar 20243:16 pmRNSHolding(s) in Company
7th Mar 20248:40 amRNSKatie Bickerstaffe - Planned Leadership Evolution
4th Mar 20243:11 pmRNSDirector/PDMR Shareholding
1st Mar 20249:00 amRNSTotal Voting Rights
28th Feb 20241:43 pmRNSDirector/PDMR Shareholding
16th Feb 20249:00 amRNSDirector Declaration
1st Feb 20249:00 amRNSTotal Voting Rights
30th Jan 20242:53 pmRNSDirector/PDMR Shareholding
15th Jan 20244:00 pmRNSDirector/PDMR Shareholding
15th Jan 20242:36 pmRNSHolding(s) in Company
11th Jan 20247:00 amRNSChristmas 2023/2024 Trading
10th Jan 20243:28 pmRNSChange To Board Committee Membership
5th Jan 20244:23 pmRNSHolding(s) in Company
2nd Jan 20249:00 amRNSBlock listing Interim Review
2nd Jan 20249:00 amRNSTotal Voting Rights
28th Dec 202311:40 amRNSDirector/PDMR Shareholding
20th Dec 202311:36 amRNSHolding(s) in Company
19th Dec 202310:30 amRNSDirector/PDMR Shareholding
14th Dec 20237:00 amRNSAdditional Listing
12th Dec 20239:13 amRNSDirector/PDMR Shareholding
1st Dec 20239:00 amRNSTotal Voting Rights
28th Nov 20232:55 pmRNSDirector/PDMR Shareholding
9th Nov 202310:29 amRNSDirector/PDMR Shareholding
8th Nov 20237:00 amRNSHalf-year Report
1st Nov 20239:00 amRNSTotal Voting Rights
30th Oct 20235:01 pmRNSDirector/PDMR Shareholding
2nd Oct 20239:00 amRNSTotal Voting Rights
28th Sep 20233:18 pmRNSDirector/PDMR Shareholding
20th Sep 20233:33 pmRNSHolding(s) in Company
20th Sep 20239:00 amRNSDirector/PDMR Shareholding
19th Sep 20239:01 amRNSDirector/PDMR Shareholding
1st Sep 20239:00 amRNSTotal Voting Rights
30th Aug 202310:34 amRNSDirector/PDMR Shareholding
16th Aug 20233:00 pmRNSDirector/PDMR Shareholding
15th Aug 20237:00 amRNSTrading Update and Outlook for the Year
1st Aug 20239:00 amRNSTotal Voting Rights
28th Jul 202311:33 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.